End capped nucleic acid molecules

The invention relates to end capped nucleic acid molecules. The disclosure relates to nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVID BARNES-SEEMAN, JOHN LOUIS DIENER, JUN YUAN, SARAH WILLIAMS, SCOTT LOUIS COHEN, CHRISTIAN GAMPE, JAMES ROACHE, FREDERIC ZECRI, AMY WHITE
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to end capped nucleic acid molecules. The disclosure relates to nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids. 本公开内容涉及末端加帽的核酸分子,尤其涉及在5'-末端、3'-末端或5'-末端和3'-末端含有修饰的核酸,并且公开了可用于制备经修饰的核酸的化合物。与未修饰的核酸相比,经修饰的核酸具有改善的表达、较低的免疫原性和改善的稳定性。